TP53 and pancreatic neoplasm: Liu et al. identified seven genes (including PTOV1-AS2) that could be used as potential candidate biomarkers for predicting the prognosis of pancreatic cancer based on a novel TP53 correlation line graph that could predict the overall survival of pancreatic cancer patients using a risk score [26].